A Psychedelic Drug Passes a Big Test for PTSD Treatment - News Summed Up

A Psychedelic Drug Passes a Big Test for PTSD Treatment


In the early 1980s, however, MDMA escaped from the clinic to the dance floor, where it became known as Ecstasy. The numbers of scientists who pursued studies with MDMA also dwindled. But a few individuals continued to push strongly on behalf of MDMA research, including Dr. Doblin, who founded his association in 1986 to focus on developing MDMA and other psychedelics into medications approved by the F.D.A. The substance binds to proteins that regulate serotonin, a neurotransmitter that can, among other things, lift mood. In 2018, the U.S. Department of Veterans Affairs spent $17 billion on disability payments for over one million veterans with PTSD.


Source: New York Times May 03, 2021 18:18 UTC



Loading...
Loading...
  

Loading...